Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « AbsEn.i » - entrée « last »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
lasofoxifene < last < lasted  Facettes :

List of bibliographic references indexed by last

Number of relevant bibliographic references: 132.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000001 (2020) A. Prasse [Allemagne] ; F. Bonella [Allemagne] ; U. Müller-Ladner [Allemagne] ; T. Witte [Allemagne] ; N. Hunzelmann [Allemagne] ; J. Distler [Allemagne][Treatment of systemic sclerosis-associated interstitial lung disease].
000006 (2020) Anna Jakubczyc ; Claus Neurohr[Interstitial lung disease in rheumatic diseases - new therapeutic approaches].
000034 (2020) Angelika Batta ; Bhupinder Singh Kalra ; Raj KhirasariaTrends in FDA drug approvals over last 2 decades: An observational study
000036 (2020) B P Hibler [États-Unis] ; A. Markova [États-Unis]Treatment of severe cutaneous adverse reaction with tocilizumab.
000113 (2020) José M. Carballido [Suisse] ; Camille Regairaz [Suisse] ; Celine Rauld [Suisse] ; Layla Raad [Suisse] ; Damien Picard [Suisse] ; Michael Kammüller [Suisse]The Emerging Jamboree of Transformative Therapies for Autoimmune Diseases
000183 (2020) Ibai Los-Arcos [Espagne] ; Juan Aguilar-Company [Espagne] ; Isabel Ruiz-Camps [Espagne]Risk of infection associated with new therapies for lymphoproliferative syndromes.
000274 (2020) Meng Hsuan Kuo [Taïwan] ; Chih-Wei Tseng [Taïwan] ; Chi-Hui Lee [Taïwan] ; Chien-Hsueh Tung [Taïwan] ; Kuo-Chih Tseng [Taïwan] ; Ning-Sheng Lai [Taïwan]Moderate Risk of Hepatitis B Virus Reactivation in HBsAg−/HBcAb+ Carriers Receiving Rituximab for Rheumatoid Arthritis
000291 (2020) Yusuf Yazici [États-Unis]Management of Behçet syndrome.
000350 (2020) Anna-Sophia Kattner ; Ernst Holler ; Barbara Holler ; Sebastian Klobuch ; Daniela Weber ; Danilo Martinovic ; Matthias Edinger ; Wolfgang Herr ; Daniel WolffIL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis
000431 (2020) Chia-Chun Tseng ; Yi-Jen Chen [Taïwan] ; Wei-An Chang [Taïwan] ; Wen-Chan Tsai ; Tsan-Teng Ou ; Cheng-Chin Wu ; Wan-Yu Sung ; Jeng-Hsien Yen ; Po-Lin Kuo [Taïwan]Dual Role of Chondrocytes in Rheumatoid Arthritis: The Chicken and the Egg
000547 (2020) Jhuma Sankar ; Nitin Dhochak ; S. K. Kabra ; Rakesh LodhaCOVID-19 in Children: Clinical Approach and Management
000568 (2020) Charlotte Laurent [France] ; Zora Marjanovic [France] ; Laure Ricard [France] ; Joerg Henes [Allemagne] ; Remy Dulery [France] ; Manuela Badoglio [France] ; Dominique Farge [France] ; John A. Snowden [Royaume-Uni] ; Daniela Moraes [Brésil] ; Juliana Dias [Brésil] ; Mohamad Mohty [France] ; Michael Soussan [France] ; Olivier Fain [France] ; Renate Arnold [Allemagne] ; Tobias Alexander [Allemagne] ; Maria-Carolina Oliveira [Brésil] ; Arsène Mekinian [France]Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in refractory Takayasu arteritis: a retrospective multicenter case-series from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT).
000573 (2020) Izabela Szczygielska ; El Bieta Hernik ; Agnieszka Gazda ; Beata Kołodziejczyk ; Piotr GietkaAssessment of anti-HBs antibody concentration in children with juvenile idiopathic arthritis treated with biological drugs, vaccinated against viral type B hepatitis in infancy
000592 (2020) Jinxin Qi [République populaire de Chine, Canada] ; Chengchao Ding [République populaire de Chine] ; Xian Jiang [République populaire de Chine] ; Yong Gao [Canada, République populaire de Chine]Advances in Developing CAR T-Cell Therapy for HIV Cure
000639 (2019) Daniela Cici ; Addolorata Corrado ; Cinzia Rotondo ; Francesco P. CantatoreWnt Signaling and Biological Therapy in Rheumatoid Arthritis and Spondyloarthritis
000661 (2019) Martina Biggioggero [Italie] ; Andrea Becciolini [Italie] ; Chiara Crotti [Italie] ; Elena Agape [Italie] ; Ennio Giulio Favalli [Italie]Upadacitinib and filgotinib: the role of JAK1 selective inhibition in the treatment of rheumatoid arthritis
000706 (2019) Martina Biggioggero [Oman] ; Chiara Crotti [Italie] ; Andrea Becciolini [Oman] ; Ennio Giulio Favalli [Oman]Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection.
000722 (2019) Filiz Yucebay [États-Unis] ; Christina Matthews [États-Unis] ; Marcin Puto [États-Unis] ; Junan Li [États-Unis] ; Basem William [États-Unis] ; Samantha M. Jaglowski [États-Unis] ; Sam L. Penza [États-Unis] ; Sumithira Vasu [États-Unis] ; Don M. Benson [États-Unis] ; Leslie A. Andritsos [États-Unis] ; Steven M. Devine [États-Unis] ; Yvonne A. Efebera [États-Unis] ; Julianna V F. Roddy [États-Unis]Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experience.
000754 (2019) Maja Zabel ; Peter A. Tauber ; Winfried F. PicklThe making and function of CAR cells
000801 (2019) Ottavia Maria Delmonte ; Luigi Daniele NotarangeloTargeted Therapy with Biologicals and Small Molecules in Primary Immunodeficiencies
000831 (2019) Laura Bazzichi [Italie] ; Francesca Nacci [Italie] ; Luigi Sinigaglia [Italie] ; Laura Bianchino [Italie] ; Roberto Caporali [Italie]Subcutaneous tocilizumab alone or with a csDMARD in rheumatoid arthritis patients: subanalysis of Italian data from a multicenter phase IIIb/IV trial.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "last" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "last" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    last
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021